ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia (2024)
Silva, Jean Carlos Lipreri da ; Silva, Juan Luiz Coelho da ; Vicari, Hugo Passos ; Lima, Keli Cristina de ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, MEDULA ÓSSEA, CÉLULAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2023.06.004. Acesso em: 13 nov. 2024. , 2024
APA
Silva, J. C. L. da, Silva, J. L. C. da, Vicari, H. P., Lima, K. C. de, Rego, E. M., Traina, F., & Machado Neto, J. A. (2024). ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.htct.2023.06.004
NLM
Silva JCL da, Silva JLC da, Vicari HP, Lima KC de, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004
Vancouver
Silva JCL da, Silva JLC da, Vicari HP, Lima KC de, Rego EM, Traina F, Machado Neto JA. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2024 ; 46( 1): 105-106.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2023.06.004
Artigo de periodico
Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells (2024)
Parducci, Natalia Sudan ; Garnique, Anali Del Milagro Bernabe ; Lima, Keli Cristina de ; Carlos, Jorge Antonio Elias Godoy ; Fonseca, Natasha Peixoto ; Miranda, Lívia Bassani Lins De ; Almeida, Bruna Oliveira de ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: BLOOD CELLS MOLECULES AND DISEASES. Unidades: FMRP, ICB, FM
Subjects: PROTEÍNAS QUINASES, ANTINEOPLÁSICOS, BAINHA DE MIELINA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARDUCCI, Natalia Sudan et al. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells. BLOOD CELLS MOLECULES AND DISEASES, v. 104, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58756. Acesso em: 13 nov. 2024.
APA
Parducci, N. S., Garnique, A. D. M. B., Lima, K. C. de, Carlos, J. A. E. G., Fonseca, N. P., Miranda, L. B. L. D., et al. (2024). Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells. BLOOD CELLS MOLECULES AND DISEASES, 104. doi:10.1016/j.bcmd.2023.102799
NLM
Parducci NS, Garnique ADMB, Lima KC de, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells [Internet]. BLOOD CELLS MOLECULES AND DISEASES. 2024 ; 104[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
Vancouver
Parducci NS, Garnique ADMB, Lima KC de, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R^T618I-driven cells [Internet]. BLOOD CELLS MOLECULES AND DISEASES. 2024 ; 104[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756
Artigo de periodico
Association between vertebral fragility fractures, muscle strength and physical performance: a cross-sectional study (2023)
Peres-Ueno, Melise Jacon; Capato, Luana Letícia; Porto, Jaqueline Mello ; Adão, Isabela Ferreira; Gomes, Jamilly Maciel ; Herrero, Carlos Fernando Pereira da Silva ; Nogueira-Barbosa, Marcello Henrique ; Paula, Francisco Jose Albuquerque de ; Ferrioli, Eduardo ; Abreu, Daniela Cristina Carvalho de
Source: Annals of Physical and Rehabilitation Medicine. Unidades: FMRP, FM
Subjects: ARTICULAÇÃO DO JOELHO, FORÇA MUSCULAR, FRATURAS, COLUNA VERTEBRAL, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES-UENO, Melise Jacon et al. Association between vertebral fragility fractures, muscle strength and physical performance: a cross-sectional study. Annals of Physical and Rehabilitation Medicine, v. 66, n. 3, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.rehab.2022.101680. Acesso em: 13 nov. 2024.
APA
Peres-Ueno, M. J., Capato, L. L., Porto, J. M., Adão, I. F., Gomes, J. M., Herrero, C. F. P. da S., et al. (2023). Association between vertebral fragility fractures, muscle strength and physical performance: a cross-sectional study. Annals of Physical and Rehabilitation Medicine, 66( 3), 1-8. doi:10.1016/j.rehab.2022.101680
NLM
Peres-Ueno MJ, Capato LL, Porto JM, Adão IF, Gomes JM, Herrero CFP da S, Nogueira-Barbosa MH, Paula FJA de, Ferrioli E, Abreu DCC de. Association between vertebral fragility fractures, muscle strength and physical performance: a cross-sectional study [Internet]. Annals of Physical and Rehabilitation Medicine. 2023 ; 66( 3): 1-8.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.rehab.2022.101680
Vancouver
Peres-Ueno MJ, Capato LL, Porto JM, Adão IF, Gomes JM, Herrero CFP da S, Nogueira-Barbosa MH, Paula FJA de, Ferrioli E, Abreu DCC de. Association between vertebral fragility fractures, muscle strength and physical performance: a cross-sectional study [Internet]. Annals of Physical and Rehabilitation Medicine. 2023 ; 66( 3): 1-8.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.rehab.2022.101680
Artigo de periodico
Differential diagnosis of bone marrow failure syndromes guided by machine learning (2023)
Gutierrez-Rodrigues, Fernanda ; Munger, Eric; Ma, Xiaoyang; Patel, Bhavisha A; Catto, Luiz Fernando Bazzo ; Clé, Diego Villa ; Paiva, Raquel de Melo Alves ; Donaires, Flávia Sacilotto ; Pinto, André Luiz; Borges, Gustavo; Santana, Bárbara Amélia Aparecida ; Pasquini, Ricardo; Velloso, Elvira Deolinda Rodrigues Pereira ; Calado, Rodrigo Tocantins
Source: Blood. Unidades: FMRP, FM
Subjects: ANEMIA, DOENÇAS DA MEDULA ÓSSEA, DIAGNÓSTICO DIFERENCIAL, HEMOGLOBINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Differential diagnosis of bone marrow failure syndromes guided by machine learning. Blood, v. 141, n. 17, p. 2100-2113, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood.2022017518. Acesso em: 13 nov. 2024.
APA
Gutierrez-Rodrigues, F., Munger, E., Ma, X., Patel, B. A., Catto, L. F. B., Clé, D. V., et al. (2023). Differential diagnosis of bone marrow failure syndromes guided by machine learning. Blood, 141( 17), 2100-2113. doi:10.1182/blood.2022017518
NLM
Gutierrez-Rodrigues F, Munger E, Ma X, Patel BA, Catto LFB, Clé DV, Paiva R de MA, Donaires FS, Pinto AL, Borges G, Santana BAA, Pasquini R, Velloso EDRP, Calado RT. Differential diagnosis of bone marrow failure syndromes guided by machine learning [Internet]. Blood. 2023 ; 141( 17): 2100-2113.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1182/blood.2022017518
Vancouver
Gutierrez-Rodrigues F, Munger E, Ma X, Patel BA, Catto LFB, Clé DV, Paiva R de MA, Donaires FS, Pinto AL, Borges G, Santana BAA, Pasquini R, Velloso EDRP, Calado RT. Differential diagnosis of bone marrow failure syndromes guided by machine learning [Internet]. Blood. 2023 ; 141( 17): 2100-2113.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1182/blood.2022017518
Artigo de periodico
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia (2023)
Catto, Luiz Fernando Bazzo ; Zanelatto, Leonardo C.; Donaires, Flávia Sacilotto ; Carvalho, Vinícius Silva de; Santana, Bárbara Amélia Aparecida ; Pinto, André L.; Fantacini, Daianne; Souza, Lucas Eduardo Botelho de ; Fonseca, Natasha Peixoto ; Telho, Bruno S.; Madeira, Maria Isabel Ayrosa; Pagnano, Katia Borgia Barbosa; Firmato, Ana Beatriz; Fagundes, Evandro Maranhão; Higashi, Márcia; Nunes, Elenaide Coutinho; Traina, Fabiola ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Calado, Rodrigo Tocantins
Source: Blood Advances. Unidades: FMRP, FM
Subjects: LINHAGEM CELULAR, LEUCEMIA MIELOIDE AGUDA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATTO, Luiz Fernando Bazzo et al. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, v. 7, n. 22, p. 7067-7078, 2023Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2023010658. Acesso em: 13 nov. 2024.
APA
Catto, L. F. B., Zanelatto, L. C., Donaires, F. S., Carvalho, V. S. de, Santana, B. A. A., Pinto, A. L., et al. (2023). Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, 7( 22), 7067-7078. doi:10.1182/bloodadvances.2023010658
NLM
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Vancouver
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Artigo de periodico
Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease (2023)
Donadel, Camila Derminio ; Silva, Bruno Garcia Peixoto Pires da; André, Nathália Cristine; Costa, Thalita Cristina de Mello; Orellana, Maristela Delgado ; Caruso, Sâmia Rigotto; Seber, Adriana; Ginani, Valéria Cortez; Gomes, Alessandra Araújo; Novis, yana; Barros, George Maurício Navarro; Vilella, Neysimélia Costa; Martinho, Glaucia Helena; Vieira, Ana Karine; Kondo, Andrea Tiemi ; Hamerschlak, Nelson ; Schmidt-Filho , Jayr; Xavier, Erick Menezes; Fernandes, Juliana Folloni ; Rocha, Vanderson Geraldo ; Covas, Dimas Tadeu ; Calado, Rodrigo Tocantins ; Cunha, Renato Luiz Guerino ; De Santis, Gil Cunha
Source: Pharmaceuticals. Unidades: FMRP, FM
Subjects: DOENÇA AGUDA, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, CÉLULAS ESTROMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DONADEL, Camila Derminio et al. Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease. Pharmaceuticals, v. 16, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16040512. Acesso em: 13 nov. 2024.
APA
Donadel, C. D., Silva, B. G. P. P. da, André, N. C., Costa, T. C. de M., Orellana, M. D., Caruso, S. R., et al. (2023). Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease. Pharmaceuticals, 16( 4), 1-12. doi:10.3390/ph16040512
NLM
Donadel CD, Silva BGPP da, André NC, Costa TC de M, Orellana MD, Caruso SR, Seber A, Ginani VC, Gomes AA, Novis yana, Barros GMN, Vilella NC, Martinho GH, Vieira AK, Kondo AT, Hamerschlak N, Schmidt-Filho J, Xavier EM, Fernandes JF, Rocha VG, Covas DT, Calado RT, Cunha RLG, De Santis GC. Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease [Internet]. Pharmaceuticals. 2023 ; 16( 4): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ph16040512
Vancouver
Donadel CD, Silva BGPP da, André NC, Costa TC de M, Orellana MD, Caruso SR, Seber A, Ginani VC, Gomes AA, Novis yana, Barros GMN, Vilella NC, Martinho GH, Vieira AK, Kondo AT, Hamerschlak N, Schmidt-Filho J, Xavier EM, Fernandes JF, Rocha VG, Covas DT, Calado RT, Cunha RLG, De Santis GC. Umbilical cord mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease [Internet]. Pharmaceuticals. 2023 ; 16( 4): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/ph16040512
Artigo de periodico
A systematic review of clinical trials for gene therapies for β-hemoglobinopathy around the world (2023)
Rós, Felipe Augusto ; Couto, Samuel Campanelli Freitas ; Lima, Jonathan Milhomens dos Santos; Ovider, Ian Costa; Maio, Karina Tozatto; Silva, Viviane Jennifer da ; Ramos, Rodrigo Nalio ; Picanço-Castro, Virgínia ; Kashima, Simone ; Calado, Rodrigo Tocantins ; Barros, Luciana Rodrigues Carvalho; Rocha, Vanderson Geraldo
Source: Cytotherapy. Unidades: FM, FMRP
Subjects: ANEMIA FALCIFORME, HEMOGLOBINAS, REVISÃO SISTEMÁTICA, DOENÇAS HEREDITÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RÓS, Felipe Augusto et al. A systematic review of clinical trials for gene therapies for β-hemoglobinopathy around the world. Cytotherapy, v. 25, n. 12, p. 1300-1306, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jcyt.2023.05.006. Acesso em: 13 nov. 2024.
APA
Rós, F. A., Couto, S. C. F., Lima, J. M. dos S., Ovider, I. C., Maio, K. T., Silva, V. J. da, et al. (2023). A systematic review of clinical trials for gene therapies for β-hemoglobinopathy around the world. Cytotherapy, 25( 12), 1300-1306. doi:10.1016/j.jcyt.2023.05.006
NLM
Rós FA, Couto SCF, Lima JM dos S, Ovider IC, Maio KT, Silva VJ da, Ramos RN, Picanço-Castro V, Kashima S, Calado RT, Barros LRC, Rocha VG. A systematic review of clinical trials for gene therapies for β-hemoglobinopathy around the world [Internet]. Cytotherapy. 2023 ; 25( 12): 1300-1306.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jcyt.2023.05.006
Vancouver
Rós FA, Couto SCF, Lima JM dos S, Ovider IC, Maio KT, Silva VJ da, Ramos RN, Picanço-Castro V, Kashima S, Calado RT, Barros LRC, Rocha VG. A systematic review of clinical trials for gene therapies for β-hemoglobinopathy around the world [Internet]. Cytotherapy. 2023 ; 25( 12): 1300-1306.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.jcyt.2023.05.006
Artigo de periodico
Time-dependent vaccine efficacy estimation quantified by a mathematical model (2023)
Loria Sorio, Jennifer ; Albani, Vinicius Viana Luiz ; Coutinho, Francisco Antonio Bezerra ; Covas, Dimas Tadeu ; Struchiner, Claudio José ; Zubelli, Jorge Passamani ; Massad, Eduardo
Source: PLOS ONE. Unidades: FMRP, FM
Subjects: SURTOS DE DOENÇAS, VACINAÇÃO, COVID-19, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LORIA SORIO, Jennifer et al. Time-dependent vaccine efficacy estimation quantified by a mathematical model. PLOS ONE, v. 18, n. 5, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54811. Acesso em: 13 nov. 2024.
APA
Loria Sorio, J., Albani, V. V. L., Coutinho, F. A. B., Covas, D. T., Struchiner, C. J., Zubelli, J. P., & Massad, E. (2023). Time-dependent vaccine efficacy estimation quantified by a mathematical model. PLOS ONE, 18( 5). doi:10.1371/journal.pone.0285466
NLM
Loria Sorio J, Albani VVL, Coutinho FAB, Covas DT, Struchiner CJ, Zubelli JP, Massad E. Time-dependent vaccine efficacy estimation quantified by a mathematical model [Internet]. PLOS ONE. 2023 ; 18( 5):[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54811
Vancouver
Loria Sorio J, Albani VVL, Coutinho FAB, Covas DT, Struchiner CJ, Zubelli JP, Massad E. Time-dependent vaccine efficacy estimation quantified by a mathematical model [Internet]. PLOS ONE. 2023 ; 18( 5):[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54811
Artigo de periodico
Influence of cerebral blood flow on volumetric loss related to Alzheimer’s disease (2023)
Agnollitto, Maria Izaura Sedoguti Scudeler ; Leoni, Renata Ferranti ; Foss, Maria Paula ; Palaretti, Júlia ; Cayres, Marcela ; Pansarim, Vítor ; Nather Junior, Júlio Cesar ; Zotin, Maria Clara Zanon ; Ferrioli, Eduardo ; Lima, Nereida Kilza da Costa Lima ; Santos, Antonio Carlos dos ; Moriguti, Júlio César
Source: Dementia & Neuropsychologia. Unidades: FMRP, FFCLRP, FM
Subjects: DOENÇA DE ALZHEIMER, IMAGEM DIGITAL, RESSONÂNCIA MAGNÉTICA, COGNIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGNOLLITTO, Maria Izaura Sedoguti Scudeler et al. Influence of cerebral blood flow on volumetric loss related to Alzheimer’s disease. Dementia & Neuropsychologia, v. 17, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1590/1980-5764-DN-2023-0004. Acesso em: 13 nov. 2024.
APA
Agnollitto, M. I. S. S., Leoni, R. F., Foss, M. P., Palaretti, J., Cayres, M., Pansarim, V., et al. (2023). Influence of cerebral blood flow on volumetric loss related to Alzheimer’s disease. Dementia & Neuropsychologia, 17, 1-11. doi:10.1590/1980-5764-DN-2023-0004
NLM
Agnollitto MISS, Leoni RF, Foss MP, Palaretti J, Cayres M, Pansarim V, Nather Junior JC, Zotin MCZ, Ferrioli E, Lima NK da CL, Santos AC dos, Moriguti JC. Influence of cerebral blood flow on volumetric loss related to Alzheimer’s disease [Internet]. Dementia & Neuropsychologia. 2023 ; 17 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1980-5764-DN-2023-0004
Vancouver
Agnollitto MISS, Leoni RF, Foss MP, Palaretti J, Cayres M, Pansarim V, Nather Junior JC, Zotin MCZ, Ferrioli E, Lima NK da CL, Santos AC dos, Moriguti JC. Influence of cerebral blood flow on volumetric loss related to Alzheimer’s disease [Internet]. Dementia & Neuropsychologia. 2023 ; 17 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1590/1980-5764-DN-2023-0004
Artigo de periodico
Hematopoietic cell transplantation for telomere biology diseases: aretrospective single‐center cohort study (2023)
Nichele, Samantha; Bonfim, Carmem; Darrigo Júnior, Luiz Guilherme ; Loth, Gisele; Kuwahara, Cilmara; Trennephol, Joanna; Funke, Vaneuza A. M.; Marinho, Daniela E.; Koliski, Adriana; Rodrigues, Adriana M.; Mousquer, Rebeca T. G.; Fasth, Anders; Lima, Alberto C. M.; Calado, Rodrigo Tocantins ; Pasquini, Ricardo
Source: European Journal of Haematology. Unidades: FMRP, FM
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, ESTUDOS RETROSPECTIVOS, TELÔMERO, DOENÇAS RARAS, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NICHELE, Samantha et al. Hematopoietic cell transplantation for telomere biology diseases: aretrospective single‐center cohort study. European Journal of Haematology, v. 111, n. 3, p. 423-431, 2023Tradução . . Disponível em: https://doi.org/10.1111/ejh.14023. Acesso em: 13 nov. 2024.
APA
Nichele, S., Bonfim, C., Darrigo Júnior, L. G., Loth, G., Kuwahara, C., Trennephol, J., et al. (2023). Hematopoietic cell transplantation for telomere biology diseases: aretrospective single‐center cohort study. European Journal of Haematology, 111( 3), 423-431. doi:10.1111/ejh.14023
NLM
Nichele S, Bonfim C, Darrigo Júnior LG, Loth G, Kuwahara C, Trennephol J, Funke VAM, Marinho DE, Koliski A, Rodrigues AM, Mousquer RTG, Fasth A, Lima ACM, Calado RT, Pasquini R. Hematopoietic cell transplantation for telomere biology diseases: aretrospective single‐center cohort study [Internet]. European Journal of Haematology. 2023 ; 111( 3): 423-431.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/ejh.14023
Vancouver
Nichele S, Bonfim C, Darrigo Júnior LG, Loth G, Kuwahara C, Trennephol J, Funke VAM, Marinho DE, Koliski A, Rodrigues AM, Mousquer RTG, Fasth A, Lima ACM, Calado RT, Pasquini R. Hematopoietic cell transplantation for telomere biology diseases: aretrospective single‐center cohort study [Internet]. European Journal of Haematology. 2023 ; 111( 3): 423-431.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/ejh.14023
Artigo de periodico
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel (2022)
Velloso, Elvira Deolinda Rodrigues Pereira ; Padulla, Georgia A. ; Cerqueira, Ana Maria Mosca de; Sousa, Adriana Martins de; Sandes, Alex Freire ; Traina, Fabiola ; Seguro, Fernanda Salles; Nogueira, Frederico Lisboa ; Pereira, Grazielly de Fathima; Boechat, jose Laerte
Source: Hematology transfusion and cell therapy. Unidades: FM, FMRP
Subjects: MASTÓCITOS, CRIANÇAS, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VELLOSO, Elvira Deolinda Rodrigues Pereira et al. Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel. Hematology transfusion and cell therapy, v. 44, n. 4, p. 582-594, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50411. Acesso em: 13 nov. 2024.
APA
Velloso, E. D. R. P., Padulla, G. A., Cerqueira, A. M. M. de, Sousa, A. M. de, Sandes, A. F., Traina, F., et al. (2022). Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel. Hematology transfusion and cell therapy, 44( 4), 582-594. doi:10.1016/j.htct.2022.04.006
NLM
Velloso EDRP, Padulla GA, Cerqueira AMM de, Sousa AM de, Sandes AF, Traina F, Seguro FS, Nogueira FL, Pereira G de F, Boechat jose L. Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel [Internet]. Hematology transfusion and cell therapy. 2022 ; 44( 4): 582-594.[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50411
Vancouver
Velloso EDRP, Padulla GA, Cerqueira AMM de, Sousa AM de, Sandes AF, Traina F, Seguro FS, Nogueira FL, Pereira G de F, Boechat jose L. Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel [Internet]. Hematology transfusion and cell therapy. 2022 ; 44( 4): 582-594.[citado 2024 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50411
Artigo de periodico
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells (2022)
Miranda, Lívia Bassani Lins De ; Lima, Keli Cristina de ; Silva, Juan Luiz Coelho ; Traina, Fabiola ; Kobayashi, Susumu S. ; Machado Neto, João Agostinho
Source: Scientific Reports. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES, TRANSDUÇÃO DE SINAL CELULAR, PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Lívia Bassani Lins De et al. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-21419-6. Acesso em: 13 nov. 2024.
APA
Miranda, L. B. L. D., Lima, K. C. de, Silva, J. L. C., Traina, F., Kobayashi, S. S., & Machado Neto, J. A. (2022). NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, 12, 1-11. doi:10.1038/s41598-022-21419-6
NLM
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Vancouver
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Artigo de periodico
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms (2022)
Costa, Amanda Fernandes de Oliveira ; Marani, Leticia Olops ; Bianco, Thiago Mantello ; Arantes, Adriana Queiroz; Lopes, Izabela Aparecida; Martins, Diego Antonio Pereira; Palma, Leonardo Carvalho ; Scheucher, Priscila Santos ; Schiavinato, Josiane Lilian dos Santos ; Silva, Cleide Lucia Araújo ; Kobayashi, Susumu S. ; Machado Neto, João Agostinho ; Rego, Eduardo Magalhães ; Welner, Robert Samuel; Pontes, Lorena Lobo de Figueiredo
Source: Frontiers in Immunology. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, MUTAÇÃO, CITOMETRIA DE FLUXO, CÉLULAS CULTIVADAS DE TUMOR, CÉLULAS DA MEDULA ÓSSEA, LEUCEMIA, CÉLULAS SANGUÍNEAS, MEDULA ÓSSEA, CÉLULAS-TRONCO, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Amanda Fernandes de Oliveira et al. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.768592. Acesso em: 13 nov. 2024.
APA
Costa, A. F. de O., Marani, L. O., Bianco, T. M., Arantes, A. Q., Lopes, I. A., Martins, D. A. P., et al. (2022). Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.768592
NLM
Costa AF de O, Marani LO, Bianco TM, Arantes AQ, Lopes IA, Martins DAP, Palma LC, Scheucher PS, Schiavinato JL dos S, Silva CLA, Kobayashi SS, Machado Neto JA, Rego EM, Welner RS, Pontes LL de F. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.768592
Vancouver
Costa AF de O, Marani LO, Bianco TM, Arantes AQ, Lopes IA, Martins DAP, Palma LC, Scheucher PS, Schiavinato JL dos S, Silva CLA, Kobayashi SS, Machado Neto JA, Rego EM, Welner RS, Pontes LL de F. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.768592
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Source: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subjects: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 13 nov. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico
Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women (2022)
Alves, Natália Maira da Cruz ; Pfrimer, Karina ; Santos, Priscila Carvalho; Freitas, Ellen Cristini de ; Neves, Thiago; Pessini, Rodrigo Antonio; Junqueira-Franco, Márcia Varella Morandi ; Nogueira-Barbosa, Marcello Henrique ; Greig, Carolyn Anne; Ferriolli, Eduardo
Source: Nutrients. Unidades: FMRP, EEFERP, FM
Subjects: SARCOPENIA, ÓLEOS DE PEIXE, FORÇA MUSCULAR, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Natália Maira da Cruz et al. Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women. Nutrients, v. 14, n. 14, p. 1-13, 2022Tradução . . Disponível em: https://doi.org/10.3390/nu14142844. Acesso em: 13 nov. 2024.
APA
Alves, N. M. da C., Pfrimer, K., Santos, P. C., Freitas, E. C. de, Neves, T., Pessini, R. A., et al. (2022). Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women. Nutrients, 14( 14), 1-13. doi:10.3390/nu14142844
NLM
Alves NM da C, Pfrimer K, Santos PC, Freitas EC de, Neves T, Pessini RA, Junqueira-Franco MVM, Nogueira-Barbosa MH, Greig CA, Ferriolli E. Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women [Internet]. Nutrients. 2022 ; 14( 14): 1-13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/nu14142844
Vancouver
Alves NM da C, Pfrimer K, Santos PC, Freitas EC de, Neves T, Pessini RA, Junqueira-Franco MVM, Nogueira-Barbosa MH, Greig CA, Ferriolli E. Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women [Internet]. Nutrients. 2022 ; 14( 14): 1-13.[citado 2024 nov. 13 ] Available from: https://doi.org/10.3390/nu14142844
Artigo de periodico
Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells (2022)
Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto ; Silva, Juan Luiz Coelho ; Scheucher, Priscila Santos ; Rego, Eduardo Magalhães ; Pontes, Lorena Lôbo Figueiredo ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Toxicology in Vitro. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, INIBIDORES QUÍMICOS, MEDULA ÓSSEA, CÉLULAS-TRONCO, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO, CÉLULAS MIELOIDES, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Jaqueline Cristina et al. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, v. 83, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2022.105384. Acesso em: 13 nov. 2024.
APA
Fernandes, J. C., Fenerich, B. A., Silva, A. B. A., Fonseca, N. P., Silva, J. L. C., Scheucher, P. S., et al. (2022). Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, 83, 1-7. doi:10.1016/j.tiv.2022.105384
NLM
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Vancouver
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Artigo de periodico-carta/editorial
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax (2022)
Lima, Keli Cristina de ; Vicari, Hugo Passos ; Carlos, Jorge Antonio Elias Godoy; Silva, Jean Carlos Lipreri da ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2021.01.004. Acesso em: 13 nov. 2024. , 2022
APA
Lima, K. C. de, Vicari, H. P., Carlos, J. A. E. G., Silva, J. C. L. da, Pontes, L. L. de F., Rego, E. M., & Machado Neto, J. A. (2022). Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2021.01.004
NLM
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Vancouver
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Artigo de periodico-carta/editorial
COVID-19 bimodal clinical and pathological phenotypes. [Carta] (2022)
Batah, Sabrina S.; Benatti, Maira N.; Siyuan, Li; Telini, Wagner M.; Barboza, Jamile O.; Menezes, Marcelo B.; Nadai, Tales Rubens de ; Sá, Keyla Santos Guedes de; Vaswani, Chirag M.; Gupta, Sahil; Zamboni, Dario Simões; Rodrigues, Rodrigo do Tocantins Calado de Saloma; Oliveira, Renê Donizeti Ribeiro de; Louzada Júnior, Paulo; Martins, Maria Auxiliadora; Louzada Júnior, Paulo; Veras, Flávio Protásio; Cunha, Larissa Dias da; Cunha, Thiago Mattar; Arruda Neto, Eurico de; Chahud, Fernando; Santos, Marcel Koenigkam; Cetlin, Andrea Antunes; Cunha, Fernando de Queiroz; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
Source: Clinical and Translational Medicine. Unidades: FM, FMRP, FCFRP
Subjects: COVID-19, FENÓTIPOS, CARTAS TERAPÊUTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATAH, Sabrina S. et al. COVID-19 bimodal clinical and pathological phenotypes. [Carta]. Clinical and Translational Medicine. Chichester: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/ctm2.648. Acesso em: 13 nov. 2024. , 2022
APA
Batah, S. S., Benatti, M. N., Siyuan, L., Telini, W. M., Barboza, J. O., Menezes, M. B., et al. (2022). COVID-19 bimodal clinical and pathological phenotypes. [Carta]. Clinical and Translational Medicine. Chichester: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/ctm2.648
NLM
Batah SS, Benatti MN, Siyuan L, Telini WM, Barboza JO, Menezes MB, Nadai TR de, Sá KSG de, Vaswani CM, Gupta S, Zamboni DS, Rodrigues R do TC de S, Oliveira RDR de, Louzada Júnior P, Martins MA, Louzada Júnior P, Veras FP, Cunha LD da, Cunha TM, Arruda Neto E de, Chahud F, Santos MK, Cetlin AA, Cunha F de Q, Fabro AT, Capelozzi VL. COVID-19 bimodal clinical and pathological phenotypes. [Carta] [Internet]. Clinical and Translational Medicine. 2022 ; 12( 1):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ctm2.648
Vancouver
Batah SS, Benatti MN, Siyuan L, Telini WM, Barboza JO, Menezes MB, Nadai TR de, Sá KSG de, Vaswani CM, Gupta S, Zamboni DS, Rodrigues R do TC de S, Oliveira RDR de, Louzada Júnior P, Martins MA, Louzada Júnior P, Veras FP, Cunha LD da, Cunha TM, Arruda Neto E de, Chahud F, Santos MK, Cetlin AA, Cunha F de Q, Fabro AT, Capelozzi VL. COVID-19 bimodal clinical and pathological phenotypes. [Carta] [Internet]. Clinical and Translational Medicine. 2022 ; 12( 1):[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/ctm2.648
Artigo de periodico
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms (2022)
Takei, Hisashi; Silva, Juan Luiz Coelho ; Leal, Cristina Tavares; Rocha, Adriana Queiroz Arantes; Bianco, Thiago Mantello ; Welner, Robert S.; Mishima, Yuta ; Kobayashi, Ikei S.; Mullally, Ann ; Lima, Keli Cristina de ; Machado Neto, João Agostinho ; Kobayashi, Susumu S. ; Pontes, Lorena Lobo De Figueiredo
Source: Cancer Science. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, PROTEÍNAS PROTO-ONCOGÊNICAS, INIBIDORES DE ENZIMAS, MODELOS ANIMAIS DE DOENÇAS, FÁRMACOS, MEDICAMENTO, NEOPLASIAS, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, CAMUNDONGOS, MUTAÇÃO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKEI, Hisashi et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, v. 113, n. 2, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1111/cas.15210. Acesso em: 13 nov. 2024.
APA
Takei, H., Silva, J. L. C., Leal, C. T., Rocha, A. Q. A., Bianco, T. M., Welner, R. S., et al. (2022). Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, 113( 2), 1-12. doi:10.1111/cas.15210
NLM
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/cas.15210
Vancouver
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1111/cas.15210
Artigo de periodico
Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial (2022)
Crippa, José Alexandre de Souza ; Pacheco, Júlia Cozar; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Campos, Alline Cristina de ; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Santos, Rafael Guimarães dos ; souza, José Diogo dos Santos; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da ; Esposito, Danillo Lucas Alves ; Passos, Afonso Dinis Costa ; Dal-Fabbro, Amaury Lelis ; Bellissimo-Rodrigues, Fernando ; Arruda, Eurico ; Scarpelini, Sandro ; Andraus, Maristela Haddad; Nather Junior, Júlio Cesar; Wada, Danilo Tadao; Santos, Marcel Koenigkam ; Santos, Antonio Carlos dos ; Busatto Filho, Geraldo ; Hallak, Jaime Eduardo Cecilio
Source: Cannabis And Cannabinoid Research. Unidades: FMRP, FM
Subjects: COVID-19, CANABINOIDES, ENSAIO CLÍNICO, DOENÇAS INFECCIOSAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, v. 7, n. 5, p. 658-669, 2022Tradução . . Disponível em: https://doi.org/10.1089/can.2021.0093. Acesso em: 13 nov. 2024.
APA
Crippa, J. A. de S., Pacheco, J. C., Zuardi, A. W., Guimarães, F. S., Campos, A. C. de, Osório, F. de L., et al. (2022). Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, 7( 5), 658-669. doi:10.1089/can.2021.0093
NLM
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1089/can.2021.0093
Vancouver
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1089/can.2021.0093

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration